Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Similar
Filing Names

Shionogi x26 Co Ltd
Shionogi x26 Co Ltd A Legal Entity Of Japan
Shionogi x26 Co Ltd_20100128
Shionogi x26 Co Ltd_20100107
  

Shionogi & Co Ltd patents

Recent patent applications related to Shionogi & Co Ltd. Shionogi & Co Ltd is listed as an Agent/Assignee. Note: Shionogi & Co Ltd may have other listings under different names/spellings. We're not affiliated with Shionogi & Co Ltd, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "S" | Shionogi & Co Ltd-related inventors




Date Shionogi & Co Ltd patents (updated weekly) - BOOKMARK this page
10/19/17Heterocyclic ring and carbocyclic derivative
10/05/17A salt of cephalosporin derivative, its crystalline solid and a manufacturing thereof
10/05/17Preparation containing cephalosporin having a catechol moiety
09/28/17Azaindole derivative having ampk-activating activity
09/28/17Monoclonal antibody, inhibiting the enzymatic activity of vascular endothelial lipase
09/21/17Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity
09/21/17Method for evaluation of drug efficacy of a medicine having a therapeutic or preventive effect against a disease related to el activity and a screening an inhibitor of el activity
09/14/17Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity
09/14/17Humanized monoclonal antibody, inhibiting the enzymatic activity of vascular endothelial lipase
09/07/17Long-acting hiv protease inhibitor
09/07/17Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity
08/24/17Heterocycle and carbocycle derivatives having trka inhibitory activity
08/24/17Methods of producing compounds having hiv integrase inhibitory activity
08/17/17Multi-layered tablet containing drug unstable to light
08/10/17Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity
08/10/17Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity
08/10/17Polycyclic pyridone derivative having integrase inhibitory activity
07/27/17Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity
07/13/17Process for producing alkynylketone derivative
07/06/17Polyene macrolide derivative
06/29/17Trpv1 antagonists including dihydroxy substituent and uses thereof
06/08/17Pyrimidinone derivative having autotaxin-inhibitory activity
05/25/17Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity
04/20/17Azabenzimidazole derivative having ampk-activating activity
04/20/17Tricyclic heterocycle derivatives having hiv replication inhibitory effect
04/20/17Pharmaceutical composition for treating chronic kidney disease
03/16/17Dihydrothiazine and dihydrooxazine derivatives having bace1 inhibitory activity
03/09/17Antiviral agent
03/09/17Aromatic 5-membered heterocyclic derivative having trpv4-inhibiting activity
03/09/17Crystal of 6,7-unsaturated-7-carbamoyl morphinan derivative and producing the same
02/09/17Medicinal agent for suppressing malignant tumor metastasis
02/02/17Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity
01/12/17Dihydrooxazine or oxazepine derivatives having bace1 inhibitory activity
12/29/16Fused pyrazole derivative having autotaxin inhibitory activity
12/22/16Substituted polycyclic carbamolypyridone derivative
11/17/16Sustained release formulation
11/10/16Sulfur-containing heterocyclic derivative having beta secretase inhibitory activity
11/03/16Pharmaceutical composition containing a compound having a thrombopoietin receptor agonistic activity
11/03/16Nitrogen-containing six-membered cyclic derivatives and pharmaceutical composition comprising the same
10/20/16Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity
09/22/16Substituted piperidin-4-amino-type compounds and uses thereof
09/08/16Novel alkylene derivatives
08/11/16Methods of producing compounds having hiv integrase inhibitory activity
08/04/16Trpv1 antagonists including dihydroxy substituent and uses thereof
07/28/16Emulsion preparation device and emulsion preparation method
07/21/16Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity
07/14/16Aromatic heterocyclylamine derivative having trpv4-inhibiting activity
07/07/16Crystal of 6,7-unsaturated-7-carbamoyl morphinan derivative and producing the same
06/30/16Novel, triazine derivative and pharmaceutical composition comprising the same
06/09/16Substituted-quinoxaline-type piperidine compounds and the uses thereof
06/09/16Oxazine derivatives
05/19/16Substituted cyclopenta[4,5]oxazolo[3,2-a]pyrido[1,2-d]pyrazines as hiv integrase inhibitors
04/28/16Aminotriazine derivative and pharmaceutical composition comprising the same
04/21/16Sulfur-containing heterocyclic derivative having beta secretase inhibitory activity
03/03/16Synthesis of carbamoylpyridone hiv integrase inhibitors and intermediates
02/25/16Novel heterocyclic derivative and pharmaceutical composition comprising the same (as amended)
02/18/16Method for detecting colon cancer
02/04/16Crystal of 6,7-unsaturated-7-carbamoyl morphinan derivative and producing the same
01/28/16Heterocyclic ring and carbocyclic derivative
01/28/16Crystal of 6,7-unsaturated-7-carbamoyl morphinan derivative and producing the same
01/14/16Substituted-quinoxaline-type bridged-piperidine compounds and the uses thereof
01/14/16Monoclonal antibody, inhibiting the enzymatic activity of vascular endothelial lipase
01/07/16Method of producing pyrone and pyridone derivatives
01/07/168-substituted imidazopyrimidinone derivative having autotaxin inhibitory activity
12/24/15Nucleoside and nucleotide having nitrogen-containing heterocycle structure
Patent Packs
12/17/15Hiv replication inhibitor
12/03/15Cephem compound
11/26/15Chemical compounds
11/26/15Nucleoside and nucleotide having sulfonamide structure
10/22/152-substituted cephem compounds
10/15/15Processes for production of intermediates for 2-alkyl cephem compounds
10/15/15Method for evaluation of drug efficacy of a medicine having a therapeutic or preventive effect against a disease related to el activity and a screening an inhibitor of el activity
09/24/15Dihydrooxazine or oxazepine derivatives having bace1 inhibitory activity
09/17/15Medicinal agent for suppressing malignant tumor metastasis
09/03/15Novel olefin derivative
08/20/15Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity
08/13/15Hiv integrase inhibitors
08/06/15Preparation containing 6,7-unsaturated-7-carbamoyl morphinan derivatives
08/06/15Preparation containing 6,7-unsaturated-7-carbamoyl morphinan derivatives
07/30/15Aminodihydrothiazine derivatives
Patent Packs
07/23/15Indole and azaindole derivative having ampk-activating activity
07/23/15Antiviral agent
07/23/15Indole and azaindole derivative having ampk-activating activity
07/02/15(3s,11ar)-6-[(phenylmethyl)oxy]-3-methyl-2,3,11,11a-tetrahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazine-5,7-dione of the formula p-9 and/or (3s,11ar)-6-[(phenylmethyl)oxy]-8-bromo-3-methyl-2,3,11,11a-tetrahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazine-5,7-dione of the formula p-10
06/18/15Oxazine derivatives
06/11/15Sulfonamide derivative having pgd2 receptor antagonistic activity
05/28/15Pharmaceutical composition containing a compound having a thrombopoietin receptor agonistic activity
05/21/15Substituted-quinoxaline-type piperidine compounds and the uses thereof
04/23/15Anti-sappbeta antibody
04/23/15Substituted polycyclic carbamoyl pyridone derivative prodrug
04/16/15Sulfur-containing heterocyclic derivative having beta secretase inhibitory activity
03/05/15Substituted polycyclic carbamoylpyridone derivative
02/26/15Method of producing n-phenyl-n'-phenylsulfonyl piperazine derivative and intermediate thereof
02/05/15Aromatic 5-membered heterocyclic derivative having trpv4-inhibiting activity
02/05/15Method of producing compounds having hiv integrase inhivitory activity
01/29/15Novel crystal form of pyrrolidylthiocarbapenem derivative
01/29/15Method for producing pyrone and pyridone derivatives
01/22/15Monoclonal antibody against el which inhibits enzyme activity of el
01/08/15Monoclonal antibody for detecting exosomes
01/08/15Azetidine-substituted quinoxaline-type piperidine compounds and uses thereof
11/06/14Trpv1 antagonists including dihydroxy substituent and uses thereof
10/30/14Oxadiazole derivative having endothelial lipase inhibitory activity
09/25/14Acetic acid amide derivative having inhibitory activity on endothelial lipase
09/11/14Polycyclic pyridone derivative having integrase inhibitory activity
09/04/14Hiv replication inhibitor
08/21/14Pyridine derivatives and a pharmaceutical composition for inhibiting bace1 containing them
07/17/14Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity
07/10/14Azabenzimidazole derivative having ampk-activating activity
04/24/14Cephem compound having pyridinium group
04/03/14Synthesis of carbamoylpyridone hiv integrase inhibitors and intermediates
Social Network Patent Pack
03/27/14Novel cephem compound having catechol or pseudo-catechol structure
03/13/14Aminodihydrothiazine derivatives substituted with a cyclic group
02/27/14Pharmaceutical composition for treating alzheimer's disease
02/20/14Oxazine derivatives and a pharmaceutical composition for inhibiting bace1 containing them
02/20/145-membered ring heteroaromatic derivatives having npy y5 receptor antagonistic activity
01/09/14Method for producing pyrazole carboxylic acid derivative
10/03/13Diagnostic methods using bnp
09/05/13Nucleic acid having an anti-metabolic syndrome effect
08/22/13Naphthyridine derivative
08/22/13Pharmaceutical composition containing optically active compound having thrombopoietin receptor agonist activity, and intermediate therefor
Patent Packs
08/15/13Fused aminodihydropyrimidine derivative
08/01/13Process for preparing aminoadamantyl carbamate derivatives
07/18/13Hetero ring-fused imidazole derivative having ampk activating effect
07/04/13Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity
06/27/13Chemical compounds
06/20/13Aminodihydrothiazine derivatives
05/09/13Pharmaceutical composition containing as an active ingredient 5-methyl-1-phenyl-2-(1h)-pyridone
05/02/13Humanized pcrv antibody having anti-pseudomonal activity
04/25/13Cephem compound having catechol group
04/18/13Pyridone derivative having integrase inhibitory activity
04/18/13Novel cephem derivative
03/28/13Cephem compound having pseudo-catechol group
03/21/13Method for producing hydroxylated adamantane using cytochrome p450
03/07/13Novel crystal form of pyrrolidylthiocarbapenem derivative
03/07/13Compounds and compositions as c-kit kinase inhibitors
11/01/12Process for the preparation of cyclohexane derivatives
11/01/12Pharmaceutical composition containing fused hetero-ring derivative
10/11/124-amino-1,3-thiazine or oxazine derivative
10/11/12Adamantanamine derivative
10/04/12Oxadiazole derivative having endothelial lipase inhibitory activity
09/27/12Substituted aminothiazine derivative
09/27/12Fused heterocyclic compound having amino group
09/27/12Oxazine derivatives
09/20/12Collagen neoepitope antibody
09/20/12Aminothiazine or aminooxazine derivative having amino linker
08/16/123-carbamoyl-2-pyridone derivatives
07/19/12Pharmaceutical composition containing as an active ingredient 5-methyl-1-phenyl-2-(1h)-pyridone
07/05/12Aminodihydrothiazine derivatives substituted with a cyclic group
05/31/126,7-unsaturated-7-carbamoyl substituted morphinan derivative
05/31/12Pharmaceutical composition comprising a lactam or benzenesulfonamide compound
Patent Packs
05/24/12Compounds having npy y5 receptor antagonistic activity
05/17/12Quinazoline derivatives having tyrosine kinase inhibitory activity
04/19/12Humanized pcrv antibody having anti-pseudomonal activity
03/22/12Urea derivatives having pi3k-inhibiting activity
02/16/12Anti-muc1 antibody
02/09/12Pharmaceutical composition for treating obesity or diabetes
01/26/12Diagnostic methods using bnp
01/26/12Acrylamide compounds and the use thereof
01/26/12Aminodihydrothiazine derivatives
01/19/12Isothiourea derivatives or isourea derivatives having bace1 inhibitory activity
01/19/12Aminodihydrothiazine derivatives
01/12/12Process for the preparation of sulfomate-carboxylate derivatives
01/05/12Cyclohexane derivative having npy y5 receptor antagonism
12/29/11Piperidine and pyrrolidine derivatives having npy y5 receptor antagonism
11/03/11Process for production of hydroxyadamantaneamine
10/13/11Piperazine derivatives
10/13/11Acetic acid amide derivative having inhibitory activity on endothelial lipase
09/29/112-aminopyrimidin-4-one and 2-aminopyridine derivatives both having bace1-inhibiting activity
09/22/11Ring-fused azole derivative having pi3k-inhibiting activity
08/04/11Cephalosporin having catechol group
Social Network Patent Pack
08/04/11Sulfur-containing heterocyclic derivative having beta secretase inhibitory activity
07/28/11Novel pyrolinone derivative and pharmaceutical composition comprising the same
07/14/11Ring-fused morpholine derivative having pi3k-inhibiting activity
07/14/11Nitrogen-containing heterocycle derivatives substituted with cyclic group
06/23/11Antibody against pcrv
05/12/11Apparatus for auto-pretreating sugar chain
05/05/11Pharmaceutical composition containing as an active ingredient 5-methyl-1-phenyl-2-(1h)-pyridone
05/05/11Heterocyclic compound having inhibitory activity on pi3k
04/28/11Coating material and container coated with the coating material
03/17/11Polypeptide and dna thereof useful as a neovascular marker
03/10/11Process for production of compound having antagonistic activity on npyy5 receptor, and useful crystal
02/03/11Pharmaceutical combination comprising vitamin k
10/28/10Amine-derivatives having npy y5 receptor antagonistic activity and the uses thereof
10/28/10Amine derivatives having npy y5 receptor antagonistic activity and the uses thereof
10/21/10Amine derivative having npy y5 receptor antagonistic activity
09/23/10Nitrogen-containing heterocyclic derivative having 11ss-hydroxysteroid dehydrogenase type i inhibitory activity
09/23/10Solid preparation comprising npyy5 receptor antagonist
09/16/10Heterocyclic derivative having inhibitory activity on type-i 11 data-hydroxysteroid dehydrogenase
08/26/10Substituted-quinoxaline-type piperidine compounds and the uses thereof
08/05/10Heterocyclic compound having type i 11 beta hydroxysteroid dehydrogenase inhibitory activity
Social Network Patent Pack
06/24/10Powder material supply device
06/24/10Pharmaceutical composition for treating alzheimer's disease
05/13/10Medicated patch comprising 5-methyl-1-phenyl-2-(1h)-pyridone
05/06/10Oxazolidinone derivative having inhibitory activity on 11beta-hydroxysteroid dehydrogenase type 1
04/29/10Process for production of hydroxyadamantaneamine
04/22/10Sulfonylurea derivative capable of selectively inhibiting mmp-13
03/25/10Aminodihydrothiazine derivatives substituted with a cyclic group
03/11/10Amine derivative having npy y5 receptor antagonistic activity
03/11/10Sulfonamide derivative having pgd2 receptor antagonistic activity
02/11/10Glucose metabolism stimulating agent
01/28/10Compounds exhibiting thrombopoietin receptor agonism
01/07/10Hydrazine amide derivative
12/24/09Compounds exhibiting thrombopoietin receptor agonism
12/10/09Liposome capable of effective delivery of given substance into nucleus
10/22/09Process for synthesis of mucin-type peptides and muc1-related glycopeptides
10/15/09Compound exhibiting pgd2 receptor antagonist
09/03/09Production container packing filler and tubular net rolling apparatus
09/03/09Process for trans-4-amino-1-cyclohexanecarboxilic acid derivatives
08/13/09Monoclonal antibody to soluble lox-1
07/02/09Heterocyclic compounds having type i 11beta hydroxysteroid dehydrogenase inhibitory activity
07/02/09Trpv1 antagonists including sulfonamide substituent and uses thereof
06/04/09Quinazoline derivatives having tyrosine kinase inhibitory activity
05/28/09Method for coating particle with lipid film
05/28/09Pharmaceutical combination comprising vitamin k
05/21/09Isoxazole derivative and isothiazole derivative having inhibitory activity on 11(beta)-hydroxysteroid dehydrogenase type i
05/21/09Cephem compounds having broad antibacterial spectrum
04/30/09Reporter gene assay
04/23/09Solid preparation having improved solubility
03/26/09Aminodihydrothiazine derivatives
03/12/09Mmp-13 selective inhibitor
Social Network Patent Pack
03/05/09Nitrogen-containing heterocycle derivatives substituted with cyclic group
01/28/10Compounds exhibiting thrombopoietin receptor agonism
01/07/10Hydrazine amide derivative
03/12/09Therapeutic agent for constipation







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Shionogi & Co Ltd in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Shionogi & Co Ltd with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';